IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE W MATHEWS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1619980919
CMS profile
163607
Location
HUMANSVILLE, MO

General Payments · PY2018–2024

$8,418.69

  • Reported across 356 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,019.84

70 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine MO All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,019.84 70

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $563.84 19
Neurocrine BioSciences, Inc. $356.94 11
Axsome Therapeutics, Inc. $255.93 3
Otsuka America Pharmaceutical, Inc. $254.43 7
ITI, Inc. $155.78 6
Xeris Pharmaceuticals, Inc. $77.70 4
Lilly USA, LLC $72.39 4
ABBVIE INC. $63.22 4
Acerta Pharma LLC $57.87 4
Novo Nordisk AS $44.58 2
Vanda Pharmaceuticals Inc. $39.92 2
Phathom Pharmaceuticals, Inc. $34.71 2
Merck Sharp & Dohme Corporation $22.18 1
Alkermes, Inc. $20.35 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,287.21 63
PY2019 $811.76 37
PY2020 $632.16 33
PY2021 $629.74 37
PY2022 $1,399.34 57
PY2023 $1,638.64 59
PY2024 $2,019.84 70

Payment records · PY2024 (70)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.16 02/26/2024 Food and Beverage Undisputed 01/23/2026 1104983243 CMS
ABBVIE INC. $16.63 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104983245 CMS
ABBVIE INC. $19.79 04/01/2024 Food and Beverage Undisputed 01/23/2026 1104983247 CMS
ABBVIE INC. $13.64 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104983249 CMS
Alkermes, Inc. $20.35 08/20/2024 Food and Beverage Undisputed 01/23/2026 1120549337 CMS
AstraZeneca Pharmaceuticals LP $13.43 03/04/2024 Food and Beverage Undisputed 01/23/2026 1105490891 CMS
AstraZeneca Pharmaceuticals LP $15.31 08/12/2024 Food and Beverage Undisputed 01/23/2026 1105665224 CMS
AstraZeneca Pharmaceuticals LP $15.33 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104202289 CMS
AstraZeneca Pharmaceuticals LP $13.80 10/21/2024 Food and Beverage Undisputed 01/23/2026 1105208449 CMS
Axsome Therapeutics, Inc. $30.88 04/15/2024 Food and Beverage Undisputed 01/23/2026 1148281759 CMS
Axsome Therapeutics, Inc. $121.61 04/16/2024 Food and Beverage Undisputed 01/23/2026 1148281757 CMS
Axsome Therapeutics, Inc. $103.44 10/08/2024 Food and Beverage Undisputed 01/23/2026 1148281761 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.31 02/12/2024 Food and Beverage Undisputed 01/23/2026 1143272597 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.20 03/25/2024 Food and Beverage Undisputed 01/23/2026 1143272601 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.46 04/29/2024 Food and Beverage Undisputed 01/23/2026 1143272604 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $93.70 06/13/2024 Food and Beverage Undisputed 01/23/2026 1143272608 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.32 07/22/2024 Food and Beverage Undisputed 01/23/2026 1143272612 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.79 10/28/2024 Food and Beverage Undisputed 01/23/2026 1143272616 CMS
Lilly USA, LLC $20.94 05/02/2024 Food and Beverage Undisputed 01/23/2026 1134999438 CMS
Lilly USA, LLC $13.85 05/28/2024 Food and Beverage Undisputed 01/23/2026 1134985998 CMS
Lilly USA, LLC $18.80 07/30/2024 Food and Beverage Undisputed 01/23/2026 1134985996 CMS
Lilly USA, LLC $18.80 09/10/2024 Food and Beverage Undisputed 01/23/2026 1134987284 CMS
Merck Sharp & Dohme LLC $22.18 08/19/2024 Food and Beverage Undisputed 01/23/2026 1141968385 CMS
Neurocrine Biosciences, Inc. $27.20 01/17/2024 Food and Beverage Undisputed 01/23/2026 1150833200 CMS
Neurocrine Biosciences, Inc. $27.20 02/14/2024 Food and Beverage Undisputed 01/23/2026 1150833176 CMS
Neurocrine Biosciences, Inc. $27.20 04/09/2024 Food and Beverage Undisputed 01/23/2026 1150833184 CMS
Neurocrine Biosciences, Inc. $27.20 05/08/2024 Food and Beverage Undisputed 01/23/2026 1150833204 CMS
Neurocrine Biosciences, Inc. $94.05 05/16/2024 Food and Beverage Undisputed 01/23/2026 1150812487 CMS
Neurocrine Biosciences, Inc. $23.92 06/11/2024 Food and Beverage Undisputed 01/23/2026 1150843390 CMS
Neurocrine Biosciences, Inc. $4.63 06/12/2024 Food and Beverage Undisputed 01/23/2026 1150888620 CMS
Neurocrine Biosciences, Inc. $31.68 09/03/2024 Food and Beverage Undisputed 01/23/2026 1150823263 CMS
Neurocrine Biosciences, Inc. $24.01 10/08/2024 Food and Beverage Undisputed 01/23/2026 1150843134 CMS
Neurocrine Biosciences, Inc. $34.72 10/16/2024 Food and Beverage Undisputed 01/23/2026 1150819208 CMS
Neurocrine Biosciences, Inc. $35.13 11/08/2024 Food and Beverage Undisputed 01/23/2026 1150818848 CMS
Novo Nordisk Inc $22.13 07/18/2024 Food and Beverage Undisputed 01/23/2026 1097609552 CMS
Novo Nordisk Inc $22.45 07/30/2024 Food and Beverage Undisputed 01/23/2026 1097108843 CMS
Otsuka America Pharmaceutical, Inc. $17.61 02/16/2024 Food and Beverage Undisputed 01/23/2026 1118937570 CMS
Otsuka America Pharmaceutical, Inc. $0.35 02/20/2024 Food and Beverage Undisputed 01/23/2026 1118937572 CMS
Otsuka America Pharmaceutical, Inc. $18.25 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118937574 CMS
Otsuka America Pharmaceutical, Inc. $72.28 04/11/2024 Food and Beverage Undisputed 01/23/2026 1118937576 CMS
Otsuka America Pharmaceutical, Inc. $21.08 06/25/2024 Food and Beverage Undisputed 01/23/2026 1118937578 CMS
Otsuka America Pharmaceutical, Inc. $21.08 10/03/2024 Food and Beverage Undisputed 01/23/2026 1118937580 CMS
Otsuka America Pharmaceutical, Inc. $103.78 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118937582 CMS
Phathom Pharmaceuticals, Inc. $19.83 02/23/2024 Food and Beverage Undisputed 01/23/2026 1151094115 CMS
Phathom Pharmaceuticals, Inc. $14.88 04/09/2024 Food and Beverage Undisputed 01/23/2026 1151094117 CMS
Teva Pharmaceuticals USA, Inc. $18.16 01/09/2024 Food and Beverage Undisputed 01/23/2026 1151714601 CMS
Teva Pharmaceuticals USA, Inc. $123.23 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151714621 CMS
Teva Pharmaceuticals USA, Inc. $14.78 02/06/2024 Food and Beverage Undisputed 01/23/2026 1151714613 CMS
Teva Pharmaceuticals USA, Inc. $14.63 03/05/2024 Food and Beverage Undisputed 01/23/2026 1151714627 CMS
Teva Pharmaceuticals USA, Inc. $2.94 04/01/2024 Food and Beverage Undisputed 01/23/2026 1151714647 CMS
Teva Pharmaceuticals USA, Inc. $20.66 04/02/2024 Food and Beverage Undisputed 01/23/2026 1151714649 CMS
Teva Pharmaceuticals USA, Inc. $3.24 04/23/2024 Food and Beverage Undisputed 01/23/2026 1151714651 CMS
Teva Pharmaceuticals USA, Inc. $18.82 05/14/2024 Food and Beverage Undisputed 01/23/2026 1151714667 CMS
Teva Pharmaceuticals USA, Inc. $19.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151714683 CMS
Teva Pharmaceuticals USA, Inc. $12.46 06/07/2024 Food and Beverage Undisputed 01/23/2026 1151714685 CMS
Teva Pharmaceuticals USA, Inc. $15.57 06/18/2024 Food and Beverage Undisputed 01/23/2026 1151714687 CMS
Teva Pharmaceuticals USA, Inc. $23.91 07/02/2024 Food and Beverage Undisputed 01/23/2026 1151714701 CMS
Teva Pharmaceuticals USA, Inc. $80.53 07/09/2024 Food and Beverage Undisputed 01/23/2026 1151714695 CMS
Teva Pharmaceuticals USA, Inc. $18.07 07/12/2024 Food and Beverage Undisputed 01/23/2026 1151714703 CMS
Teva Pharmaceuticals USA, Inc. $123.23 08/08/2024 Food and Beverage Undisputed 01/23/2026 1151714715 CMS
Teva Pharmaceuticals USA, Inc. $16.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 1151714725 CMS
Teva Pharmaceuticals USA, Inc. $5.19 11/19/2024 Food and Beverage Undisputed 01/23/2026 1151714737 CMS
Teva Pharmaceuticals USA, Inc. $16.30 11/20/2024 Food and Beverage Undisputed 01/23/2026 1151714739 CMS
Teva Pharmaceuticals USA, Inc. $16.26 12/04/2024 Food and Beverage Undisputed 01/23/2026 1151714741 CMS
Vanda Pharmaceuticals Inc. $16.88 05/16/2024 Food and Beverage Undisputed 01/23/2026 1133911932 CMS
Vanda Pharmaceuticals Inc. $23.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 1133911934 CMS
Xeris Pharmaceuticals, Inc. $18.30 07/19/2024 Food and Beverage Undisputed 01/23/2026 1144595320 CMS
Xeris Pharmaceuticals, Inc. $20.68 08/30/2024 Food and Beverage Undisputed 01/23/2026 1144595322 CMS
Xeris Pharmaceuticals, Inc. $17.17 10/07/2024 Food and Beverage Undisputed 01/23/2026 1144595324 CMS
Xeris Pharmaceuticals, Inc. $21.55 11/25/2024 Food and Beverage Undisputed 01/23/2026 1144595326 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.